Malignant mixed mesodermal tumor of the ovary treated with a cisplatin-irinotecan combination: case report.
Azevedo
P
P
Multidisciplinary Gynecologic Cancer Center, The University of Texas, M.D. Anderson Cancer Center, Houston Texas 77030, USA.
Verschraegen
C F
CF
Kavanagh
J J
JJ
Kudelka
A P
AP
Freedman
R S
RS
Lu
K
K
Deavers
M T
MT
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000008:administration & dosage / Q000031:analogs & derivatives; D002945:Cisplatin / Q000008:administration & dosage; D004791:Enzyme Inhibitors / Q000008:administration & dosage; D005260:Female; D006801:Humans; D000077146:Irinotecan; D008875:Middle Aged; D018199:Mixed Tumor, Mesodermal / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D012074:Remission Induction; D059004:Topoisomerase I Inhibitors
D004791:Enzyme Inhibitors; D059004:Topoisomerase I Inhibitors; D000077146:Irinotecan; D002945:Cisplatin; D002166:Camptothecin